Hot Topics In Bipolar: Reasons For The Elevated Risk Of Suicide In Patients Diagnosed With Bipolar I Disorder
Dr. Mauricio Tohen addresses current and relevant clinical questions relating to bipolar disorder. These questions and Dr. Tohen’s responses have been recorded and will be released as short videos every month.
“What are some reasons for the elevated risk of suicide in patients diagnosed with bipolar I disorder?”
Mauricio Tohen, MD, DrPH, MBA
Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico
- Evidence Supporting The Use Of Long-Acting Injectables As A Way To Prevent Relapse In Patients Diagnosed With Bipolar I Disorder (May 2023)
- Starting A Long-Acting Injectable Treatment For Bipolar I Patients That May Be Reluctant To Receiving An Injectable Medication (June 2023)
- Long-Acting Injectables Affect Adherence To Other Non-Antipsychotic Oral Medications In Bipolar I Patients (July 2023)
- Long-Acting Injectable Treatment For Patients Diagnosed With Bipolar I Disorder (August 2023)
- Youth Mental Health Crisis In The United States (October 2023)
- Co-occurring Substance Use Disorders Impact The Evaluation & Treatment Of Bipolar I Disorder (November 2023)
- Prevalence Of Nonadherence To Treatment In Bipolar I Disorder & The Subsequent Impact On The Patient & Caregivers (December 2023)
If you or someone you know is in crisis,
call 988 or the Suicide Prevention Hotline/Lifeline 1-800-273-TALK(8255)
or text the Crisis Text Line 741-741
Mauricio Tohen, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
-
Factors in Designing & Evaluating Clinical Trials for App-Based Interventions
In this webinar, Dr. Sara Morimoto, PsyD will share her expertise in developing and testing app-based mental health interventions.